08 May 2015, Nikkei Biotech ONLINE

Strategia Therapeutics licensed in E6201 from Eisai, Japan: Dr. Keizo Koya, CEO and President of Strategia Therapeutics, truly wants to rescue promising shelved drug candidates to transform into valuable drugs for patients in need

Link to Article